treated an adult patient with a BRAF V600E pilocytic astrocytoma with vemurafenib, a B-raf inhibitor, and cobimetinib, a MEK inhibitor, with 1-year follow-up showing tumor stability and reduction of T2 cord signal cranial and caudal to the lesion (76). The gene discussed is BRAF; the disease is pilocytic astrocytoma.